Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine plus crocin for inflammatory bowel disease
IRCT20230511058153N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Salcrozine and acetaminophen in Crohn's disease, autoimmune colitis and inflammatory bowel disease (IBD), sponsored by Shahrekord University of Medical Sciences. Started Jun 2023; status: completed.
02
Drugs
Salcrozineacetaminophen
03
Conditions
Crohn's diseaseautoimmune colitisinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on IRCT20230511058153N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230511058153N1.